Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Fisher & Paykel Healthcare Corporation Limited (FPH) vs. Competitors

3 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
NZ:FPHFisher & Paykel Healthcare Corporation LimitedNZD 48.48NZD 28.52B60.3627.31%Strong BuyUnlock the NZ:FPH analyst price target with TipRanks PremiumNZ:FPHUnlock the NZ:FPH top-analyst price target with TipRanks Premium
NZ:EBOEBOS Group LimitedNZD 21.40NZD 4.47B16.75-25.25%Strong BuyUnlock the NZ:EBO analyst price target with TipRanks PremiumNZ:FPH vs NZ:EBOUnlock the NZ:EBO top-analyst price target with TipRanks Premium
NZ:PEBPacific Edge LimitedNZD 0.28NZD 341.52M-7.0557.14%HoldUnlock the NZ:PEB analyst price target with TipRanks PremiumNZ:FPH vs NZ:PEBUnlock the NZ:PEB top-analyst price target with TipRanks Premium
NZ:RYMRyman HealthcareNZD 1.89NZD 1.92B-11.34-35.49%Moderate BuyUnlock the NZ:RYM analyst price target with TipRanks PremiumNZ:FPH vs NZ:RYMUnlock the NZ:RYM top-analyst price target with TipRanks Premium
NZ:TRUTruScreen Group Ltd.NZD 0.01NZD 8.38M-2.58-47.37%―Unlock the NZ:TRU analyst price target with TipRanks PremiumNZ:FPH vs NZ:TRUUnlock the NZ:TRU top-analyst price target with TipRanks Premium
NZ:AFTAFT Pharmaceuticals Ltd.NZD 4.52NZD 474.03M31.9739.51%Moderate BuyUnlock the NZ:AFT analyst price target with TipRanks PremiumNZ:FPH vs NZ:AFTUnlock the NZ:AFT top-analyst price target with TipRanks Premium

Performance Comparison

-50%-25%0%25%50%75%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
NZ:FPHFisher & Paykel Healthcare Corporation Limited48.4811.5031.10%
NZ:EBOEBOS Group Limited21.40-6.48-23.24%
NZ:PEBPacific Edge Limited0.280.1162.72%
NZ:RYMRyman Healthcare1.89-0.96-33.68%
NZ:TRUTruScreen Group Ltd.0.01-0.01-44.44%
NZ:AFTAFT Pharmaceuticals Ltd.4.521.3442.36%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts